Research Paper Volume 15, Issue 23 pp 14242—14262
Two lncRNA signatures with cuproptosis as a novel prognostic model and clinicopathological value for endometrioid endometrial adenocarcinoma
Figure 2. Evaluation of the established cuproptosis-related lncRNAs signature in the training and test sets. (A–C) Kaplan-Meier survival analysis in the training (A), validation (B) and all samples (C) sets. (D) ROC curves for risk scores at 1, 2, and 3 years. (E, F) Expression heat map, risk score distribution, and relapse status.